Executive (NASDAQ: CLOV) schedules Rule 144 share sale and details past trades
Filing Impact
Filing Sentiment
Form Type
144
Rhea-AI Filing Summary
Jamie Reynoso reports an intention under Rule 144 to sell up to 4,839 shares of CLOV common stock through Morgan Stanley Smith Barney LLC, with an indicated value of $21,291.60. The notice also lists multiple prior common-stock sales between June 11 and July 15, 2026, some under 10b5-1 plans.
Positive
- None.
Negative
- None.
Key Figures
Planned shares to be sold: 4,839 shares
Planned sale value: $21,291.60
Sale on 07/15/2026: 13,119 shares; $61,265.73
+1 more
4 metrics
Planned shares to be sold
4,839 shares
Common stock proposed for sale under Rule 144
Planned sale value
$21,291.60
Indicated value of 4,839 CLOV shares in planned Rule 144 sale
Sale on 07/15/2026
13,119 shares; $61,265.73
CLOV common stock sold by Jamie Reynoso on July 15, 2026
Sale on 06/11/2026
7,289 shares; $35,752.71
CLOV common stock sold by Jamie Reynoso on June 11, 2026
Key Terms
Rule 144, Restricted Stock Units, 10b5-1 Sales
3 terms
Rule 144 regulatory
"144: Securities To Be Sold"
Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.
Restricted Stock Units financial
"Common | 07/15/2026 | Restricted Stock Units | Issuer"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
10b5-1 Sales regulatory
"10b5-1 Sales for JAMIE REYNOSO 1209 Orange Street"
10b5-1 sales are pre-arranged stock-trading plans that let company insiders automatically buy or sell shares according to a fixed schedule or formula, even if they later learn confidential information. Think of it as setting up an automatic thermostat for trades: it creates a clear, documented path that can protect insiders from insider-trading accusations and gives investors a signal about predictable insider activity—though it can also simply be a way for insiders to diversify or raise cash.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What does the CLOV Form 144 notice disclose?
The notice discloses that Jamie Reynoso intends to sell up to 4,839 shares of CLOV common stock under Rule 144 through Morgan Stanley Smith Barney LLC, and lists several prior stock sales over the previous three months.
What recent CLOV stock sales by Jamie Reynoso are listed?
Listed sales include 13,119 shares for $61,265.73 on July 15, 2026, plus several earlier June and July 2026 transactions in CLOV common stock, some identified specifically as 10b5-1 Sales.
What is the role of Morgan Stanley Smith Barney LLC in the CLOV Form 144?
Morgan Stanley Smith Barney LLC is listed as the broker handling the planned Rule 144 transaction, associated with the proposed sale of 4,839 CLOV common shares valued at $21,291.60 as of the notice.
Are the CLOV stock sales by Jamie Reynoso made under a 10b5-1 plan?
Some, but not all, of the listed transactions are labeled as 10b5-1 Sales. Specific entries in June and July 2026 identify themselves that way, indicating those particular trades followed a pre-arranged trading plan.
What type of CLOV securities are involved in Jamie Reynoso’s planned sale?
The Form 144 relates to common stock of CLOV, associated with Restricted Stock Units dated July 15, 2026, and routed for sale through Morgan Stanley Smith Barney LLC under Rule 144.